Vidarbha News

Female Infertility Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies – Abbott, Merck Pharmaceuticals Ferring Pharmaceutic

 Breaking News
  • No posts were found

Female Infertility Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies – Abbott, Merck Pharmaceuticals Ferring Pharmaceutic

April 20
01:21 2023
Female Infertility Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies - Abbott, Merck Pharmaceuticals Ferring Pharmaceutic
DelveInsight Business Research LLP
DelveInsight’s “Female Infertility Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Female Infertility, historical and forecasted epidemiology as well as the Female Infertility market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight’s “Female Infertility Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Female Infertility, historical and forecasted epidemiology as well as the Female Infertility market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Female Infertility Overview

Female infertility refers to infertility in women. It affects an estimated 48 million women, with the highest prevalence of infertility affecting women in South Asia, Sub-Saharan Africa, North Africa/Middle East, Central/Eastern Europe, and Central Asia. Many sources, including nutrition, diseases, and other malformations of the uterus cause infertility. Infertility affects women worldwide, and the cultural and social stigma surrounding it varies.

 

Female Infertility Epidemiology Insights

  • A woman’s fertility is affected by her age. The average age of a girl’s first period is 12–13 (12.5 years in the, 12.72 in  12.9 in the but in postmenarchal girls, about 80% of the cycles are in the first year after menarche, 50% in the third, and 10% in the sixth year. A woman’s fertility peaks in the early and mid-20s, after which it starts to decline, with this decline being accelerated after age 35. However, the exact estimates of the chances of a woman to conceive after a certain age are not clear, with research giving differing results. The chances of a couple successfully conceiving at an advanced age depend on many factors, including the general health of a woman and the fertility of the male partner.

  • Menopause typically occurs between 44 and 58 years of age. DNA testing is rarely carried out to confirm claims of maternity at advanced ages, but in one large study, among 12,549 African and Middle Eastern immigrant mothers, confirmed by DNA testing, only two mothers were found to be older than fifty; the oldest mother being 52.1 years at conception (and the youngest mother 10.7 years old)

The Report Covers the Female Infertility Epidemiology Segmented by:

  • Female Infertility total incident cases 

  • Female Infertility total prevalent cases 

  • Female Infertility diagnosed cases 

  • Female Infertility treatment cases  

  • Female Infertility cases based on age 

  • Female Infertility cases based on body weight 

  • Female Infertility cases based on eating disorder 

Female Infertility Market Outlook 

The Female Infertility market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Female Infertility market trends by analyzing the impact of current Female Infertility therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Female Infertility market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Female Infertility market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Female Infertility market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Female Infertility Market

  • Abbott 

  • Merck Pharmaceuticals 

  • Ferring Pharmaceuticals 

  • AstraZeneca 

  • Sanofi 

And many others 

Female Infertility Therapies Covered and Analyzed in the Report:

  • Dydrogesterone

  • FSH-GEX

  • Bravelle

  • Follitropin Alfa

  • Menotropin

And many others 

Table of Contents 

  1. Key Insights 

  2. Female Infertility Market  Introduction 

  3. Executive Summary of Female Infertility Market   

  4. Disease Background and Overview

  5. Epidemiology and patient population

  6. Female Infertility Market Emerging Therapies

  7. Female Infertility Market Market Outlook

  8. Market Access and Reimbursement of Therapies

  9. Market Drivers 

  10. Market Barriers 

  11. Appendix

  12. Report Methodology

  13. DelveInsight Capabilities

  14. Disclaimer

Learn about the detailed offerings of the report @ Female Infertility Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Categories